New malaria treatment plan put to the test in peru

NCT ID NCT05361486

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study looked at whether a new way to treat Malaria Vivax is practical for healthcare workers in Peru. The plan includes a simple test to check a patient's G6PD enzyme level before giving one of two medicines, tafenoquine or primaquine. Researchers trained healthcare providers and followed up with patients after 3 days to see if the new steps were followed correctly. 187 patients took part, and the goal was to see if this approach could work in real-world clinics.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALARIA VIVAX are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Plasmodium vivax malaria

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Nauta Nucleo- Base

    Nauta, Loreto, 16310, Peru